Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Bloomia Holdings (NASDAQ:TULP) Fiscal Q1 2027 Earnings: Revenue, Gross Loss and Cash Use

Operating loss was USD 3.11 million, compared with USD 3.04 million, and operating loss as a percentage of revenue was 62.6%, compared with 59.1%.

Nitish Kishor | 16 November 2026

TherapeuticsMD (NASDAQ:TXMD) Q3 2026 Earnings: License Revenue, Net Income and Royalties

For the nine months ended September 30, 2026, license revenue was USD 2.85 million, compared with USD 2.13 million, and net income was USD 741 thousand, compared with USD 50 thousand.

Nitish Kishor | 16 November 2026

United-Guardian (NASDAQ:UG) Q3 2026 Earnings: Net Sales Growth and Higher Net Income

Net income was USD 930.9 thousand, compared with USD 268.4 thousand in the third quarter of 2025. Income from operations was USD 1.11 million, compared with USD 215.1 thousand.

Nitish Kishor | 16 November 2026

Unicycive Therapeutics (NASDAQ:UNCY) Q3 2026 Earnings: Net Loss, Expenses and Cash Position

Research and development expense was USD 2.25 million, compared with USD 2.96 million. General and administrative expense was USD 6.60 million, compared with USD 4.38 million. Total operating expenses, which equal the loss from operations, were USD 8.84 million, compared with USD 7.34 million.

Nitish Kishor | 16 November 2026

Venu Holding (NYSE American:VENU) Q3 2026 Earnings: Revenue, Operating Loss and Cash

Restaurant including food and beverage revenue, net, was USD 3.04 million, compared with USD 2.27 million. Event center ticket and fees revenue, net, was USD 1.89 million, compared with USD 2.76 million, and rental and sponsorship revenue, net, was USD 0.62 million, compared with …

Nitish Kishor | 16 November 2026

Veritone (NASDAQ:VERI) Q3 2026 Earnings: Revenue, Net Loss and Financing Update

Cost of revenue, exclusive ofDepreciationand amortization, was USD 6.25 million, compared with USD 8.44 million. Sales andMarketingexpense was USD 10.49 million, compared with USD 10.51 million,Research and Developmentexpense was USD 5.96 million, compared with USD 5.49 million, and general and administrative expense was USD …

Nitish Kishor | 16 November 2026

Village Farms (NASDAQ:VFF) Q3 2026 Earnings Show Record Cannabis Revenue and International Growth

Management saidNet Incomewas USD 10 million, or USD 0.08 per share, and that consolidated net sales were USD 67 million, up 5% sequentially. The company's president and chief executive officer, Michael DeGiglio, led the call alongside other senior executives.

Nitish Kishor | 16 November 2026

Verde Clean Fuels (NASDAQ:VGAS) Q3 2026 Earnings Report: Narrower Net Loss and Cash Position

The operating loss was USD 2.46 million, compared with USD 2.88 million. The company reported the figures in its quarterly filing for the period ended September 30, 2026.

Nitish Kishor | 16 November 2026

Vistagen Therapeutics (NASDAQ:VTGN) Fiscal Q2 2027 Earnings: Lower Research Spending and Narrower Loss

The net loss was USD 10.74 million, compared with USD 19.42 million, and the loss from operations was USD 10.94 million, compared with USD 20.05 million.

Nitish Kishor | 16 November 2026

Virtuix Holdings (NASDAQ:VTIX) Fiscal Q2 2027 Earnings: Net Sales, Net Loss and Omni One Growth

Cost of goods sold was USD 0.89 million, compared with USD 0.58 million, andGross Profitwas USD 0.30 million, compared with USD 0.41 million. Selling expenses were USD 0.92 million, compared with USD 0.35 million, general and administrative expenses were USD 4.01 million, compared with …

Nitish Kishor | 16 November 2026
Support

Hi! How can we help you today?

Loading…